IBD: Ulcerative Colitis

Biosimilars for IBD: Making the Transition Webinar

 

On May 28th, Dr. McCurdy answered the following questions in a very informative webinar presentation on Biosimilars:

  • What’s the difference between a reference biologic drug and a biosimilar?
  • Biosimilars: What’s Health Canada saying?
  • What is the clinical evidence to date?
  • How do doctors go about transitioning their patients from a reference biologic drug to a biosimilar?

Watch this webinar now!

Biosimilars for IBD: Making the Transition Webinar

  [embed]https://www.youtube.com/watch?v=XG3F9LyMS5g&feature=youtu.be[/embed] On May 28th, Dr. McCurdy answered the following questions in a very informative webinar presentation on Biosimilars:
  • What’s the difference between a reference biologic drug and a biosimilar?
  • Biosimilars: What’s Health Canada saying?
  • What is the clinical evidence to date?
  • How do doctors go about transitioning their patients from a reference biologic drug to a biosimilar?
Watch this webinar now!